SCHEMBL25253290

SCHEMBL25253290

COc1cccc(CN(Cc2ccc(N3CCCC3)cc2)c2ccc(CN3CCCCC3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.51
KDM4E B2RXH2 5/20 0.51
ALDH1A1 P00352 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.49
CASP1 P29466 1/20 0.48
CASP4 P49662 1/20 0.48
CASP5 P51878 1/20 0.48
LMNA P02545 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47
GFER P55789 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
DRD2 P14416 2/20 0.45
DRD4 P21917 2/20 0.45
GAA P10253 1/20 0.45
F2R P25116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245515 1.00 SIGMAR1 (0.51) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL25262872 0.95 KDM4E (0.51) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL30245608 0.95 KDM4E (0.51) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL30244958 0.94 KDM4E (0.47) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL25260056 0.94 KDM4E (0.47) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL30245261 0.94 SIGMAR1 (0.52) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL25258578 0.94 KDM4E (0.57) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL30245308 0.94 KDM4E (0.57) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL25253276 0.93 SMN1; SMN2 (0.50) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL30245806 0.93 SMN1; SMN2 (0.50) SIGMAR1KDM4EALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 WO disclosed